Lecanemab, known as the brand name Leqembi, is the first drug approved by the FDA that slows cognitive decline in Alzheimer's patients — but there are still questions about the long-term efficacy and safety. NBC’s Maria Shriver reports for TODAY on the hope it’s giving to some families.
